Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| OPLØST EFTER FUSION | 11.09.2019 | 11.09.2019 |
| NORMAL | 15.09.2000 | 10.09.2019 |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| Forskning og eksperimentel udvikling indenfor bioteknologi (721100) | 01.01.2008 | 11.09.2019 |
| Forskning og udvikling inden for naturvidenskab og teknik (731000) | 01.01.2003 | 31.12.2007 |
| Fremstilling af farmaceutiske råvarer (244100) | 18.04.2001 | 31.12.2002 |
| Uoplyst (980000) | 15.09.2000 | 17.04.2001 |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| false | 10.05.2001 | 11.09.2019 |
| Virksomheden har ikke ændret Revision i sin
levetid. |
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| mail@acebiosciences.com | 08.06.2004 | 09.12.2004 |
| Virksomheden har ikke ændret Kontakt i sin
levetid. |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| 72270000 | 04.02.2019 | 11.09.2019 |
| 65652121 | 21.05.2001 | 22.11.2009 |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| ACE BIOSCIENCES ApS | 05.07.2019 | 11.09.2019 |
| ACE BIOSCIENCES A/S | 09.03.2001 | 04.07.2019 |
| ACE BIOSCIENCES ApS | 07.12.2000 | 08.03.2001 |
| SCSK 5502 ApS | 15.09.2000 | 06.12.2000 |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| ACE BIOMAPS A/S | 10.05.2001 | 04.07.2019 |
| ACE BIOMAPS ApS | 15.09.2000 | 09.03.2001 |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| Selskabet tegnes af en direktør | 05.07.2019 | 11.09.2019 |
| Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening, idet bestyrelsesmedlemmet dog ikke samtidig må være direktør. Selskabet kan endvidere tegnes af tre medlemmer af bestyrelsen i forening og den samlede bestyrelse | 27.11.2014 | 04.07.2019 |
Ingen nuværende registrering.
Type af revisorbistand:Revisionspåtegning
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s responsibilities for the audit of the financial statements section of this auditor’s report. We are independent of the Entity in accordance with the International Ethics Standards Board of Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Ace BioSciences A/S for the financial year 01. 01. 2018 - 31. 12. 2018, which comprise the income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the Entity’s financial position at 31. 12. 2018 and of the results of its operations for the financial year 01. 01. 2018 - 31. 12. 2018 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the management commentary.
Our opinion on the financial statements døs not cover the management commentary, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the management commentary and, in doing so, consider whether the management commentary is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the management commentary provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the management commentary is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management commentary.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration